期刊文献+

乳腺癌Her-2基因检测方法对比 被引量:11

下载PDF
导出
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2007年第2期225-226,共2页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献5

  • 1Swiatoniowski G, Dabrowska M. Klaiewski T, et al. Erb-2 overexpression in breast cancer[J].Ginekol Pol.2003. 74(4): 332-338.
  • 2曾瑄,赵大春,周炜洵,武莎斐,梁智勇,刘彤华.荧光原位杂交检测乳腺癌HER2基因状态[J].中华病理学杂志,2005,34(11):701-705. 被引量:65
  • 3Hammock L, Lewis M, Phillips C, et al. Strong HER-2/neu protein overexpression by immunohistoehemistry often does not predict oncogene amplification by fluorescence in situ hybridizalion [J]. Hum Pathol, 2005,36: 1043-1047.
  • 4虞有智,姜宝玉,陈定宝,沈丹华.显色原位杂交技术在乳腺癌HER-2/neu原癌基因检测上的应用及意义[J].中华病理学杂志,2006,35(1):51-52. 被引量:9
  • 5Gupta D, Middlelon L P, Whitaker M J, et al. Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast caneer [J]. Am J Clin Pathol, 2003. 119: 381-387.

二级参考文献23

  • 1曾瑄,赵大春,周炜洵,武莎斐,梁智勇,刘彤华.荧光原位杂交检测乳腺癌HER2基因状态[J].中华病理学杂志,2005,34(11):701-705. 被引量:65
  • 2Press MF,Bernstein L,Thomas PA,et al.HER-2/neu gene amplification characterized by fluorescence in situ hybridization:poor prognosis in node-negative breast carcinomas.J Clin Oncol,1997,15:2894-2904.
  • 3Ratclitte N,Wells W,Wheeler K,et al.The combination of in situ hybridization and immunohistochemical analysis:an evaluation of HER-2/neu expression in paraffin-embedded breast carcinomas and adjacent normal-appearing breast epithelium.Mod Pathol,1997,10:1247-1252.
  • 4Tanner M,Gancberg D,DiLeo A,et al.Chromogenic in situ hybridization:a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.Am J Pathol,2000,157:1467-1472.
  • 5Zhao JX,Wu R,Au A,et al.Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma.Mod Pathol,2002,15:657-665.
  • 6Gupta D,Middleton LP,Whitaker MJ,et al.Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in braest cancer.Am J Clin Pathol,2003,119:381-387.
  • 7Van de Vijver MJ. Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2).Eur J Cancer, 2001, 37Suppl 1: 11-17.
  • 8Ross JS, Gray GS. Targeted therapy for cancer: the HER-2/neu and Herceptin story. Clin Leadersh Manag Rev, 2003, 17:333-340.
  • 9Vogel-C, Cobieigh MA, Tripathy D? et al. First-line, single-agent Herceptin ( R ) ( trastuzumab ) in metastatic breast cancer: a preliminary report. Eur J Cancer, 2001, 37 Suppl 1:25-29.
  • 10Hammock L, Lewis M, Phillips C, et al. Strong Her-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization. Hum Pathol, 2005,36 : 1043-1047.

共引文献71

同被引文献166

引证文献11

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部